Reply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab

scientific article published on 13 August 2014

Reply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CNCR.28947
P932PMC publication ID4440419
P698PubMed publication ID25123754

P2093author name stringOliver Sartor
Charles L Bennett
Kenneth R Carson
Scott D Newsome
P2860cites workPML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease SectionQ30613846
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports projectQ33383576
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) ProjectQ37568787
P433issue24
P407language of work or nameEnglishQ1860
P921main subjectdoxorubicinQ18936
progressive multifocal leukoencephalopathyQ704930
non-Hodgkin lymphomaQ1138590
P304page(s)4006-4007
P577publication date2014-08-13
P1433published inCancerQ326041
P1476titleReply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab
P478volume120

Reverse relations

Q39705818Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting systemcites workP2860

Search more.